Thanks for everything! I will miss being around in the lab but see you online 🫶🏻

Had a lovely dinner today with members of @s-j-aitken.bsky.social’s lab to celebrate my recent preprint! Sharing these small milestones (and the joy that comes with them) with friends is just magic ✨

This project has been with me since day 1 in the lab - a long journey of challenges, growth & incredible teamwork 🚀

So proud of @gmaci.bsky.social team for pushing this work to the finish line! Thks to collaborators (#Barbacid & #FSanchezVega labs) and @caixaresearch.bsky.social for their support

Tracking ongoing chromosomal instability using single-cell whole-genome sequencing Chromosomal instability (CIN) generates aneuploid genomes that are characteristic of most cancers. While bulk genome sequencing reveals historical CIN, it lacks the resolution to identify ongoing CIN ...

📢 New preprint out!

We are thrilled to introduce our framework to track #ongoingCIN by leveraging single-cell genomics and CIN signatures:

www.biorxiv.org/content/10.1...

It was an honor to take part in the @yalepathology.bsky.social research retreat today! Great science, inspiring discussions, a fun “guess who?”, and wonderful people. Huge thanks to organizers for such a great work! Can’t believe only 2 months left to enjoy this amazing #AitkenLab team ✨

A trio of talks this week: Grand Rounds @jhu.edu yesterday. Then @bhernando.bsky.social (who has only been here a fortnight!) and I gave talks at the NYC Genome Integrity Discussion group @rockefeller.edu. Thanks for inviting us Agata Smogorzewska and Philipp Oberdoerffer

@yalepathology.bsky.social

Exciting 3 months ahead at the #AitkenLab @yaleschoolofmed.bsky.social! 🤩

Huge thanks to @s-j-aitken.bsky.social for the warm welcome, and to @caixaresearch.bsky.social for supporting my research career at all levels ✨

#CNIOStopCancer develop test that predicts which patients will not respond to cancer chemotherapy. They have identified biomarkers which, in clinical practice, would allow for more effective treatments and the avoidance of side effects.

http://bit.ly/465QqnR

Un estudio del #CNIOStopCancer descubre biomarcadores que predicen qué pacientes no responderán a la quimioterapia contra el cáncer. Podrían servir para descartar tratamientos que no van a funcionar, pero provocan efectos secundarios y son caros. 

http://bit.ly/4lj1QJn

🚨Chemo treatment upgrade!🚨

Check out our approach to modernise chemotherapy treatment published today in @natgenet.nature.com. From @cniostopcancer.bsky.social #TailorBio @cruk-ci.bsky.social www.nature.com/articles/s41... More details 👇

💥New preprint from the @gmaci.bsky.social lab!

Thrilled to share this major team effort, with #Angel as co-first author, now live on bioRxiv!

Check out our threat to learn more about our work👇

Flying back from Bologna after the Pan Prostate Cancer Group #PPCG meeting. 3 days of fruitful discussions with lovely colleagues at the best venue I have ever been 🤩

Chromosome Segregation and Aneuploidy Aneuploidy is a hallmark of cancer and developmental disorders such as Down syndrome. Understanding how cells accomplish faithful chromosome segregation and how chromosomal instability (CIN) impacts …

Day 1 at #AACR2025 from my side! Meanwhile, at the #EMBO workshop on Chromosome Segregation and Aneuploidy, Maria Escobar will be presenting our project on ongoing CIN in KRAS mutant pancreatic organoids! A must meeting for the #CIN community meetings.embo.org/event/25-ane...

Ready for #AACR25! Excited for five full days of talks, posters and educational sessions in cancer research, and also for catching up with colleagues and friends 🤩